HERON THERAPEUTICS, INC. /DE/ (HRTX) Gross profit 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual gross profit history from SEC filings — each fiscal year as reported.
$113.6MFY2025 · since FY2016: $1.2M → $113.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $113.6M | +7.5% |
| FY2024 | $105.6M | +70.6% |
| FY2023 | $61.9M | +17.3% |
| FY2022 | $52.8M | +30.9% |
| FY2021 | $40.3M | -23.1% |
| FY2020 | $52.4M | -37.8% |
| FY2019 | $84.3M | +68.8% |
| FY2018 | $50.0M | +90.8% |
| FY2017 | $26.2M | +2004.4% |
| FY2016 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice